Modern Chinese Medicine Group Co. Ltd. has released its interim results for the six months ended 30 June 2025. The company reported a revenue decrease of approximately 15.4%, dropping from RMB76.6 million in the previous period to RMB64.8 million in the current period. Despite the decline in revenue, the company recorded a shift from a loss of RMB6.9 million in the previous period to earnings of RMB2.5 million for the current period. This improvement in profitability is also reflected in the earnings per share, which turned from a loss of RMB1.14 cents to earnings of RMB0.41 cents. The gross profit also saw a decrease of approximately 25.3%, falling from RMB21.7 million to RMB16.2 million. The company managed to improve its profit before tax, reporting a figure of RMB3.43 million compared to a loss of RMB4.33 million in the previous period. Additionally, other income, gains, and losses netted RMB1.41 million, a significant improvement from a loss of RMB8.41 million in the previous period. No specific updates regarding the company's business operations or future outlook were provided in the interim results announcement.